Patent Assignment
Reel/Frame 063318/0849
RELEASE OF SECURITY INTEREST
Recorded: 2023-04-13
Received: 2023-04-13
Pages: 10
Assignor
ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Executed: 2023-04-13
Assignees
AMRYT PHARMACEUTICALS, INC.
45 MESPIL ROAD, DUBLIN, IEX, 4, IRELAND
AMRYT ENDO, INC.
160 FEDERAL STREET, 21ST FLOOR, BOSTON, MA, 02110, UNITED STATES
AMRYT RESEARCH LIMITED
90 HARCOURT STREET, DUBLIN, IEX, 2, IRELAND
AMRYT GENETICS LIMITED
90 HARCOURT STREET, DUBLIN, IEX, 2, IRELAND
Covered Applications
(33)
SYSTEM FOR SECURING VERIFICATION KEY FROM ALTERATION AND VERIFYING VALIDITY OF A PROOF OF CORRECTNESS
App. No. 18/134,276
→
ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
App. No. 17/545,729
→
TERLIPRESSIN COMPOSITIONS AND THEIR METHODS OF USE
App. No. 17/524,022
→
ORAL OCTREOTIDE THERAPY AND CONTRACEPTIVE METHODS
App. No. 17/470,836
→
BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION
App. No. 17/393,171
→
METHODS FOR FORMING POLYPLEXES
App. No. 17/418,067
→
COMPOSITIONS AND METHODS FOR TRANSFECTING CELLS
App. No. 17/284,607
→
ORAL OCTREOTIDE THERAPY AND CONTRACEPTIVE METHODS
App. No. 17/135,328
→
ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
App. No. 17/135,081
→
BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION
App. No. 17/120,678
→
METHOD OF TREATING DISEASES
App. No. 17/094,238
→
METHODS OF DETECTING ANTI-LEPTIN NEUTRALIZING ANTIBODIES
App. No. 16/996,281
→
PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
App. No. 16/990,071
→
METHOD OF TREATING DISEASES
App. No. 16/881,348
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
App. No. 16/751,538
→
TERLIPRESSIN COMPOSITIONS AND THEIR METHODS OF USE
App. No. 16/343,232
→
METHOD OF TREATING DISEASES
App. No. 16/233,749
→
ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
App. No. 16/071,630
→
ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
App. No. 15/972,557
→
COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
App. No. 15/570,246
→
Methods of Detecting Anti-Leptin Neutralizing Antibodies
App. No. 15/702,719
→
USE OF AN OLEOGEL CONTAINING TRITERPENE FOR HEALING WOUNDS
App. No. 15/142,679
→
PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
App. No. 15/044,949
→
METHOD OF TREATING DISEASES
App. No. 15/014,634
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/837,705
→
A CHIMERIC LEPTIN POLYPEPTIDE AND METHOD OF USING THE SAME
App. No. 14/703,523
→
PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
App. No. 14/188,139
→
TRITERPENE-CONTAINING OLEOGEL-FORMING AGENT, TRITERPENE-CONTAINING OLEOGEL AND METHOD FOR PRODUCING A TRITERPENE-CONTAINING OLEOGEL
App. No. 13/970,898
→
USE OF AN OLEOGEL CONTAINING TRITERPENE FOR HEALING WOUNDS
App. No. 13/509,416
→
PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
App. No. 13/281,129
→
PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
App. No. 13/233,824
→
COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
App. No. 11/547,568
→
TRITERPENE-CONTAINING OLEOGEL-FORMING AGENT, TRITERPENE-CONTAINING OLEOGEL AND METHOD FOR PRODUCING A TRITERPENE-CONTAINING OLEOGEL
App. No. 11/630,180
→